Information
Our pipeline information has been updatedNew!!

GEXVal Inc.February 14, 2025 Our pipeline information has been updated. Pipeline - GEXVal For further informat […]

Read more
R&D
GEXVal Receives Funding from a Parkinson’s Research Program at The Michael J. Fox FoundationNew!!

GEXVal Inc.February 14, 2025 GEXVal Inc. (President & CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, […]

Read more
IR
GEXVal Raises JPY 300M and Partners with Alfresa Holdings

GEXVal Inc.January 16, 2025 GEXVal Completes Additional Funding of JPY 300 Million in Series C Extension Round […]

Read more
Information
FRAXA Research Foundation Features GEXVal's Development Program

GEXVal Inc.January 6, 2025 We are delighted to announce that FRAXA Research Foundation1) has featured GEXVal I […]

Read more
R&D
GEXVal Selected for AMED’s ‘Strengthening Program for Pharmaceutical Startup Ecosystem’

GEXVal Inc.16 December, 2024 We are delighted to announce that GEXVal Inc.'s planned global Phase 2a Proof of […]

Read more